OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized control trials
Po‐Yu Huang, Tinghui Liu, Jheng‐Yan Wu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 13

Showing 13 citing articles:

Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19
Jheng‐Yan Wu, Mei‐Yuan Liu, Tinghui Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 18

SARS-CoV-2 genomics and impact on clinical care for COVID-19
Ramon Lorenzo‐Redondo, Alexandre Machado de Sant’Anna Carvalho, Judd F. Hultquist, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. Supplement_2, pp. ii25-ii36
Open Access | Times Cited: 9

Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2)
Isolde Sommer, Dominic Ledinger, Kylie Thaler, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 10, pp. 1377-1385
Open Access | Times Cited: 8

Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence
Ioannis Karniadakis, Nikolaos Mazonakis, Constantinos Tsioutis, et al.
Infectious Disease Reports (2023) Vol. 15, Iss. 6, pp. 662-678
Open Access | Times Cited: 7

Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis
Huzaifa Ahmad Cheema, Saleha Abdul Rab, Momina Butt, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 3, pp. 396-402
Open Access | Times Cited: 2

Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study
Wiessam Abu Ahmad, Ronen Arbel, Yael Wolff Sagy, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 10, pp. 1305-1311
Closed Access | Times Cited: 1

Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients
Shu-Farn Tey, Ya‐Wen Tsai, Jheng‐Yan Wu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1

Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID‐19: A systematic review and meta‐analysis
Bahman Amani, Behnam Amani
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 1

The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer
Wan‐Hsuan Hsu, Bo-Wen Shiau, Ya‐Wen Tsai, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 8, pp. 102465-102465
Open Access

Use of molnupiravir in patients who developed SARS-CoV2-Infection during hospitalization
Gülçin Telli Dizman, İbrahim Yahya Çakır, Gamze Korubük, et al.
Acta Medica (2023) Vol. 54, Iss. 3, pp. 252-257
Open Access

Page 1

Scroll to top